Have multiple conditions? Click here

New Clinical Trials for Rheumatoid Arthritis

While there is a lot known about rheumatoid arthritis its underlying cause remains a mystery. If you qualify there are rheumatoid arthritis clinical trials being conducted that you can participate in at no cost to you. This painful and often debilitating disease affects thousands in how they feel and how they can function in every day tasks. It is hoped that through continued rheumatoid arthritis clinical research economical and safe ways of treating this disease can be discovered. Ultimately we all hope to find a cure as well. 
 

What is Rheumatoid Arthritis?

Rheumatoid arthritis is a chronic inflammatory disease that attacks certain joints in the body. The cause is unknown, but it is known that autoimmunity plays a role. Rheumatoid arthritis is characterized by destruction of the joints that causes pain and limits mobility. It affects approximately 1% of the population worldwide and is most commonly found in the hands, feet and spine. The destruction caused to the joints is often so severe that it causes deformity. Joint stiffness and pain are often worse first thing in the morning or after a period of not moving. Its cause has been linked to genetics and also to smoking.
 

Rheumatoid Arthritis Treatments

Rheumatoid arthritis treatments include physical therapy, rest, medications, and more recently, biologics. Physical therapy, occupational therapy and nutritional therapy have been shown to improve movement and flexibility, but they do not slow down the disease. Painkillers, anti-inflammatory drugs, and steroids are often prescribed as treatment for rheumatoid arthritis. Unfortunately many rheumatoid arthritis treatments help the symptoms, but may hurt recovery in the long run. Disease-modifying medications (DMARDs) are necessary to slow or halt the disease. Recently biologic treatments that focus on vaccines, blood and gene therapies have seen some success.

Have multiple conditions? Click here

Showing 1-100 of 1003
There are 1003 Rheumatoid Arthritis Clinical Trials
Name City State Zip
Rheumatoid Arthritis Clinical Trial Birmingham AL 35216
Rheumatoid Arthritis Clinical Trial Birmingham AL 35216
Rheumatoid Arthritis Clinical Trial DeLand FL 32720
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) Tuscaloosa AL 35406
Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA) Huntsville AL 35801
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) Huntsville AL 35801
Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis Birmingham AL 35294
BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis Birmingham AL
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry) Birmingham AL 35233
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis Birmingham AL 35294
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs Birmingham AL
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-Inhibitor Birmingham AL
AMG 827 in Rheumatoid Arthritis Subjects With Inadequate Response to Methotrexate Birmingham AL
Golimumab in Rheumatoid Arthritis Patients With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Birmingham AL
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis Birmingham AL
Evaluation of SAR153191(REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Birmingham AL 35205
Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Birmingham AL
Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository Birmingham AL 35233
A Study of Tocilizumab [RoActemra/Actemra] Versus Adalimumab in Patients With Rheumatoid Arthritis Birmingham AL
Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia Birmingham AL
A Study of the Effects of Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) Birmingham AL 35209
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Birmingham AL
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. Birmingham AL
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding. Birmingham AL
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist Birmingham AL
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients Birmingham AL
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis Birmingham AL 35209
Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA) Birmingham AL
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen Alabaster AL 35007
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis Alabaster AL 35007
Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors Alabaster AL 35007
A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis Alabaster AL 35007
Augmentâ„¢ Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions Tucson AZ 85712
A Study in Patients With Rheumatoid Arthritis on Background Methotrexate Therapy Scottsdale AZ 85259
A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate Scottsdale AZ 85259
A Rheumatoid Arthritis Study in Patients Scottsdale AZ 85259
A Study in Patients With Rheumatoid Arthritis Scottsdale AZ 85259
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis Phoenix AZ 85023
AMG 827 in Rheumatoid Arthritis Subjects With Inadequate Response to Methotrexate Phoenix AZ
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients Phoenix AZ
Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA) Phoenix AZ
Post-Market Study of the 3DKneeâ„¢ System Peoria AZ
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs Peoria AZ
Open-label Study to Assess the Safety and Efficacy of CDP6038 in Patients Who Completed RA0056 Peoria AZ
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-Inhibitor Peoria AZ
Golimumab in Rheumatoid Arthritis Patients With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Peoria AZ
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis Peoria AZ
Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Peoria AZ
A Study of Tocilizumab [RoActemra/Actemra] Versus Adalimumab in Patients With Rheumatoid Arthritis Peoria AZ
Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia Peoria AZ
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Peoria AZ
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis Peoria AZ
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Peoria AZ
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) Paradise Valley AZ 85253
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) Paradise Valley AZ 85253
Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) Paradise Valley AZ 85253
Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) Paradise Valley AZ 85253
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis Gilbert AZ 85234
A Study of the Effects of Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) Chandler AZ 85224
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis Chandler AZ 85224
Safety and Effectiveness Study of Ascension's PyroCarbon Radial Head Compared to Ascension's Metal Radial Head Van Buren AR 72957
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs Little Rock AR
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-Inhibitor Little Rock AR
Golimumab in Rheumatoid Arthritis Patients With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Little Rock AR
A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis Little Rock AR
Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis Little Rock AR 72205
A Study of Tocilizumab [RoActemra/Actemra] Versus Adalimumab in Patients With Rheumatoid Arthritis Little Rock AR
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Little Rock AR
Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA) Hot Springs AR 71913
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen Fayetteville AR 72703
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis Fayetteville AR 72703
A Phase 4, 6-Week, Randomized Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects Fayetteville AR 72703
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX Fayetteville AR 72703
A Study of the Effects of Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) Fayetteville AR 72703
A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate Fayetteville AR 72703
A Rheumatoid Arthritis Study in Patients Fayetteville AR 72703
A Study in Patients With Rheumatoid Arthritis Fayetteville AR 72703
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) West Hills CA 91307
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) Walnut Creek CA 94598
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) Victorville CA 92395
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis Stanford CA 94305
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis Stanford CA 94305
Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository Stanford CA 94305
Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA Stanford CA 94305
An Observational Study on The Safety and Effectiveness of Mabthera (Rituximab) in The First Six Months of Treatment in Patients With Severe Active Rheumatoid Arthritis South San Francisco CA
An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab) South San Francisco CA
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy Sepulveda CA 91343
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy Santa Maria CA 93454
Evaluation of SAR153191(REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Santa Maria CA 94354
Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers Santa Maria CA 94354
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs Santa Clara CA 95051
A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA) Santa Clara CA 95051
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-Inhibitor Santa Clara CA 95051
Golimumab in Rheumatoid Arthritis Patients With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Santa Clara CA 95051
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis Santa Clara CA 95051
A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis Santa Clara CA 95051
Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Santa Clara CA 95051
A Study of Tocilizumab [RoActemra/Actemra] Versus Adalimumab in Patients With Rheumatoid Arthritis Santa Clara CA 95051
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Santa Clara CA 95051
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis Santa Clara CA 95051

Showing 1-100 of 1003
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register